Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
Ibrutinib in treatment for refractory or relapsed CLL
The differences in treating older versus younger CLL patients
Era of personalized therapy in CLL
What are the best molecular diagnostic techniques in CLL?